Healthcare Global Enterprises Limited (NSE: HCG), ISIN INE075I01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HCG last traded at ₹674.95 (-0.57%), with a 52-week range of ₹513.40 to ₹799.47 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 64.21%, FIIs 2.75%, DIIs 18.91%, mutual funds 15.31%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.